Early research (Phase 1)Study completedNCT00390338What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Pawel Kalinski 22
Testing effectiveness (Phase 2)Study completedNCT01119508What this trial is testingIpilimumab + Temozolomide in Metastatic MelanomaWho this might be right forMetastatic Melanoma M.D. Anderson Cancer Center 64
Early research (Phase 1)WithdrawnNCT00006126What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryWho this might be right forBreast CancerKidney CancerLung Cancer+2 more Northwestern University
Early research (Phase 1)UnknownNCT03353402What this trial is testingFecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed ImmunotherapyWho this might be right forMelanoma Stage IvUnresectable Stage III Melanoma Sheba Medical Center 40
Large-scale testing (Phase 3)Study completedNCT02908672What this trial is testingAtezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced MelanomaWho this might be right forMelanoma Hoffmann-La Roche 514
Early research (Phase 1)UnknownNCT00037037What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic MelanomaWho this might be right forMelanoma (Skin) Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01970527What this trial is testingPhase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV MelanomaWho this might be right forRecurrent MelanomaStage IV Skin Melanoma University of Washington 23
Testing effectiveness (Phase 2)Ended earlyNCT00138229What this trial is testingCyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic MelanomaWho this might be right forMelanoma (Skin) National Institutes of Health Clinical Center (CC) 6
Testing effectiveness (Phase 2)Study completedNCT00003229What this trial is testingVaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor RemovalWho this might be right forMelanoma (Skin) Duke University
Testing effectiveness (Phase 2)Study completedNCT00948480What this trial is testingVaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic CellsWho this might be right forMetastatic Melanoma Hoag Memorial Hospital Presbyterian 56
Early research (Phase 1)WithdrawnNCT04955262What this trial is testingA CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and NivolumabWho this might be right forMetastatic Melanoma Nektar Therapeutics
Testing effectiveness (Phase 2)Study completedNCT02257424What this trial is testingDabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant MelanomaWho this might be right forAdvanced BRAF Mutant Melanoma Abramson Cancer Center at Penn Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00050102What this trial is testingComparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic MelanomaWho this might be right forMelanoma Bristol-Myers Squibb
Not applicableStudy completedNCT02949154What this trial is testingElevated LDH Serum Levels and FDG-PET in Metastatic Melanoma PatientsWho this might be right forMelanoma University Medical Center Groningen 65
Early research (Phase 1)Study completedNCT00833807What this trial is testingHepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the LiverWho this might be right forMelanomaLiver Metastasis M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07750067What this trial is testingTunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant MelanomaWho this might be right forMelanoma MetastaticNRAS Mutation Sun Yat-sen University 37
Large-scale testing (Phase 3)Ended earlyNCT01280565What this trial is testingMasitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-KitWho this might be right forMetastatic Melanoma AB Science 134
Very early researchLooking for participantsNCT05498792What this trial is testingStudy of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in MelanomaWho this might be right forLocally Advanced or Metastatic Melanoma Fox Chase Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05034536What this trial is testingPD-1 Antibody Therapy + Infliximab for Metastatic MelanomaWho this might be right forMetastatic Melanoma Massachusetts General Hospital 36
Testing effectiveness (Phase 2)Study completedNCT00019734What this trial is testingVaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)